CTRI/2018/01/011403
Completed
Phase 4
Evaluation of â??Quality of Lifeâ?? and in-use tolerance in women with facial melasma, after using a triple combination drug (TRI-LUMA Cream)
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Galderma India Private Limited
- Enrollment
- 33
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Participants with moderate to severe melasma on the face.
- •Childbearing potential patient with highly effective contraceptive methods
- •Willing to avoid unusual sun exposure as far as possible for the entire study duration.
Exclusion Criteria
- •Patients with prior history of mometasone based triple combination melasma therapy or under hormonal replacement therapy including usage of OC pills
- •If Patients were immunocompromised or were under immunosuppressive treatment, or had contraindications for corticosteroid treatment
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
ASSESSMENT OF QUALITY OF LIFE OF TUBERCULOSIS PATIENTSCTRI/2021/11/038300I
Completed
Not Applicable
Quality of Life in lung cancer patient with brain metastasis.CTRI/2013/01/003299A140
Recruiting
Not Applicable
Application observation on quality of life and cohabitation problems in patients with the suburethral PVDF band DynaMesh®-SIS (soft)N39.3Stress incontinenceDRKS00033888FEG Textiltechnik Forschungs- und Entwicklungsgesellschaft mbH100
Completed
Phase 2
Comparison of Quality of life and Periodontal health status in pre and postmenopausal women. This is A Cross sectional studyCTRI/2020/03/024349none25
Not yet recruiting
Not Applicable
Comparing Quality of Life: Psoriasis Patients vs. General Population - Insights from a Cross-Sectional StudyHealth Condition 1: L088- Other specified local infections of the skin and subcutaneous tissueCTRI/2024/05/067585Datta Meghe Institude of Higher Education and Research